Literature DB >> 6866714

The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.

T B Vree, Y A Hekster, M W Tijhuis, M Baakman, T J Janssen, E F Termond.   

Abstract

Sulfadiazine, sulfamerazine, sulfadimidine and their corresponding N4-acetyl derivatives were administered to man. The percentages of acetylation and deacetylation, protein binding, half-lives of elimination and apparent and true renal clearance values were measured. Methyl substitution in the N1-pyrimidine ring favours acetylation by an additional N-acetyltransferase isoenzyme present in 'fast' acetylators only. Methyl substitution in the N1-pyrimidine ring favours renal clearance of the N4-acetylsulfonamide derivatives. The N1-substituent probably reinforces the binding of the N4-acetyl group to the active tubular transport mechanism. The renal clearance of these sulfonamides is not dependent on the structure of the N1-substituent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866714     DOI: 10.1007/bf01960075

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  13 in total

1.  HUMAN ACETYLATION POLYMORPHISM.

Authors:  D A EVANS; T A WHITE
Journal:  J Lab Clin Med       Date:  1964-03

2.  [Influencing of the tubular function in renal excretion of 4-sulfanilamido-2, 6-dimethylpyrimidine].

Authors:  F PORTWICH; H BUTTNER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

3.  Clinical toxicity of sulfonamides.

Authors:  D LEHR
Journal:  Ann N Y Acad Sci       Date:  1957-10-12       Impact factor: 5.691

4.  Acetylation and deacetylation of the p-amino group of sulphonamide drugs in animal tissues.

Authors:  H A Krebs; W O Sykes; W C Bartley
Journal:  Biochem J       Date:  1947       Impact factor: 3.857

5.  The mechanism of isoniazid acetylation by human N-acetyltransferase.

Authors:  W W Weber; S N Cohen
Journal:  Biochim Biophys Acta       Date:  1968-01-08

Review 6.  Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives.

Authors:  C A Hekster; T B Vree
Journal:  Antibiot Chemother (1971)       Date:  1982

7.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

8.  Polymorphic acetylation of sulphadimidine in normal and uraemic man.

Authors:  T Talseth; K H Landmark
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

9.  [Physicochemical and biological studies on sulfonamides. 1. Pharmacologically interesting physicochemical characteristics of 21 sulfonamides and 6 sulfonamide metabolites].

Authors:  J RIEDER
Journal:  Arzneimittelforschung       Date:  1963-02

10.  Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.

Authors:  T B Vree; Y A Hekster; J E Damsma; M Tijhuis; W T Friesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more
  2 in total

1.  Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.

Authors:  T B Vree; Y A Hekster; M W Tijhuis; M Baakman; M J Oosterbaan; E F Termond
Journal:  Pharm Weekbl Sci       Date:  1984-08-24

2.  Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs.

Authors:  T B Vree; M W Tijhuis; J F Nouws; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1984-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.